However, such coverage comes with strict eligibility requirements, such as patients needing an extremely high BMI and associated health conditions
Key takeaways Population mortality By 2045, incretin-based drugs such as GLP-1s could reduce mortality in the US by 3.5% in a central scenario, 8.8% in an optimistic scenario, and 1.0% in a pessimistic scenario In the same central scenario, mortality could decrease by 2.0% in the UK, 2.6% in Canada and 1.4% in Hong Kong
Barrier methods, like condoms, are advised for 4 weeks after starting or increasing the dose, or a non-oral birth control could be used, such as the IUD, vaginal ring, or hormonal implant (6)
[DOI] [PMC free article] [PubMed] [Google Scholar] [40].Jarade C, Zolotarova T, Moiz A, Eisenberg MJ
Generics vs